- Home
- BNR vs CLPS Comparison
BNR vs CLPS Comparison
Compare BNR & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- CLPS
- Stock Information
- Founded
- BNR 2014
- CLPS 2005
- Country
- BNR China
- CLPS Hong Kong
- Employees
- BNR N/A
- CLPS N/A
- Industry
- BNR Medical Specialities
- CLPS Computer Software: Prepackaged Software
- Sector
- BNR Health Care
- CLPS Technology
- Exchange
- BNR Nasdaq
- CLPS Nasdaq
- Market Cap
- BNR 38.3M
- CLPS 26.0M
- IPO Year
- BNR 2020
- CLPS 2018
- Fundamental
- Price
- BNR $4.63
- CLPS $1.00
- Analyst Decision
- BNR
- CLPS
- Analyst Count
- BNR 0
- CLPS 0
- Target Price
- BNR N/A
- CLPS N/A
- AVG Volume (30 Days)
- BNR 20.0K
- CLPS 12.3K
- Earning Date
- BNR 08-21-2025
- CLPS 03-05-2025
- Dividend Yield
- BNR N/A
- CLPS 13.27%
- EPS Growth
- BNR N/A
- CLPS N/A
- EPS
- BNR N/A
- CLPS N/A
- Revenue
- BNR $72,112,038.00
- CLPS $153,816,045.00
- Revenue This Year
- BNR $136.32
- CLPS N/A
- Revenue Next Year
- BNR N/A
- CLPS N/A
- P/E Ratio
- BNR N/A
- CLPS N/A
- Revenue Growth
- BNR 0.53
- CLPS 5.81
- 52 Week Low
- BNR $2.18
- CLPS $0.68
- 52 Week High
- BNR $7.90
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- BNR 73.56
- CLPS 59.17
- Support Level
- BNR $3.06
- CLPS $0.90
- Resistance Level
- BNR $3.50
- CLPS $0.94
- Average True Range (ATR)
- BNR 0.24
- CLPS 0.03
- MACD
- BNR 0.11
- CLPS 0.01
- Stochastic Oscillator
- BNR 82.64
- CLPS 100.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.